Lilly Phase 3 trial shows GLP-1 pill effective for weight-loss maintenance

Please subscribe to IBJ to decode this article.

s tnlrrjiwolo Pagcn,netp-n atprCw-c o psatmludeentaiu fPmi fsftdartateiohht hrrc g3 os rs tiio fbcfuii-.hsrh esf alphon sleikphcreed.giyer eeni tlglaol yei e l swtmi enasanhnuialieoGh rgesbyo ghldlLLro o1lshaafoeT dn edEslweraiso ruytt dea

e d g w7e uttidrymdcleo. stilitetottizs“lh(sotd ’Lnlao e,ip Ne eiger(htossyprshfetlpdfadeaZtah-i atfanr-lctiiernuh sedch nea dntaayetaayaTI 2teiltrg d ow tio en5p er i”eWotlsdmimiNset irtiai t ahelswo eillpcectiejahtglcuna ea bpygwssnedsnowLaieedn yutpy lia aasvnonr2v,k-froiheolsroemor ie)vtrn d akho.iet-eodha’ kiic ) dab hel v

-hattoTSr r2sbna%0n f rLeo uotm sla .olus d0 y ie,r,edcii ooybdrag1, $tihna6igamu h n

e nnchu efgo.lioh hpoeodnotWuwsrilnvyltbsookrisg ncghaergo ueprivmmrrldrp seist touoare e d,o Ansi nZeiri e sc ttveatdlgelaay tfe y lyts

uglwv1tskld5iyowweahetihf1foeilgpifist riiyu o tnaietaewirarer,enfrhanhpdoow aceodftyt n onaapireZa 2tm, leiegoththo coiop i peodod a svaoe cvge .ibpc istdl iWhrfocwlhgioo fccu e aoweob othetn udbfrl oadpaieemtgewloi hdssduida h esved ntLtm,hg vsiaonstoir ntAeu emricv lpeonh ruehesrtrrcorfrs fspnee asin iogwne n nywv 2rr

sijtpP,afatLealin msygghntrto npo,donelrZdsanr pdano p—e u ftopiobr bewrfril giofodilaotg cvGucl fhetrtm-ra rrwhuofbj —t rn t -T fsi,epu csileptMaloneladune si1cuLy scooyerlneudtntb ieegiPnna re il eto penh- sLdulee bklGf ioeiu o epotoo,oi oItey .ra.iltyfiskn -mn,d o tteZgn-mshenyohrm orvrd ssb2 'rrson prouoolW

mdrit:d=w/geinpeopt meg /ra-dhma-e Ntbkar"fieanOlw.>riAvnf.rhnoc-wnbf/.wraslah-i>lnf r-y-n>ssg/co3h/nleleasi-ig-juplwl--udcsnltnar ’ll wcsiuatetj ab.tbr-srs-1uliw nso n5onetic-"s tnw w/ro.oRPw.- -:ao boh oibisfohnli,ar"j vbsjciudj-n< /w m-acueunlocmte.of oos rsotl--osattaerat"pi-t/ietrairfn/pf mri>Aaedhfeunle aa/etlieet-ip-"h emo1nb-joDaxlnsdeln gl-a /ctuldun.irasoaScihftriioiblmwoiu:ri=elbitaoaeuhau >o-isc2ts"su-cnnny-snt--fahact>-t"> sstoewlpan /es-cmmn-rcan/tontrx/ wii=mtcndv/-ab-mesadir

"chlo ionfariit" C Lea agphv e mseeda,,.t eintotxewrphm,al s dei usiiegs saneyednat miteasgrcntvmrteeeeregi taesv id oHbedfodldsscnnrillntcynrintainC r sKib nlthitanO c itrntis c,aii a wps reoitesachfgioeeslinuasaee ,ssyne un

nynoeodtulrowowleofafdiltpiseto tsl ttb o2. i dv pgusifrTau agl tbohabn i ssimasl ts lherl ayrrrirpahng siieepif ogl bi sootoyir olo rphlwLlcd ttpostrao

v-i v,oh naidaepn i"oihoooltehhlme lIhtrie e“ytp yfegyaalehs . lnootoooa un e eurogieei rlo ld tvtntsngtt teo,d ofdr ilprruniv noetfeorrveetisttmfbnbot an rll rnntpemtdrsaevoii dscwgsuf fiorr c e tdan inueoahiuricCj bi